CZ20011655A3 - Léčivo pro léčení diabetes mellitus a stavů s ním spojených a farmaceutický prostředek obsahující beta -agonistu a daląí antidiabetické činidlo - Google Patents

Léčivo pro léčení diabetes mellitus a stavů s ním spojených a farmaceutický prostředek obsahující beta -agonistu a daląí antidiabetické činidlo

Info

Publication number
CZ20011655A3
CZ20011655A3 CZ20011655A CZ20011655A CZ20011655A3 CZ 20011655 A3 CZ20011655 A3 CZ 20011655A3 CZ 20011655 A CZ20011655 A CZ 20011655A CZ 20011655 A CZ20011655 A CZ 20011655A CZ 20011655 A3 CZ20011655 A3 CZ 20011655A3
Authority
CZ
Czechia
Prior art keywords
agonist
medicament
diabetes mellitus
pharmaceutical preparation
connected therewith
Prior art date
Application number
CZ20011655A
Other languages
Czech (cs)
English (en)
Inventor
Jonathan Robert Sanders Arch
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CZ20011655A3 publication Critical patent/CZ20011655A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
CZ20011655A 1998-11-11 1999-11-11 Léčivo pro léčení diabetes mellitus a stavů s ním spojených a farmaceutický prostředek obsahující beta -agonistu a daląí antidiabetické činidlo CZ20011655A3 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment

Publications (1)

Publication Number Publication Date
CZ20011655A3 true CZ20011655A3 (cs) 2002-06-12

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011655A CZ20011655A3 (cs) 1998-11-11 1999-11-11 Léčivo pro léčení diabetes mellitus a stavů s ním spojených a farmaceutický prostředek obsahující beta -agonistu a daląí antidiabetické činidlo

Country Status (15)

Country Link
EP (1) EP1128845A1 (tr)
JP (1) JP2002529430A (tr)
KR (1) KR20010075698A (tr)
CN (1) CN1332638A (tr)
AU (1) AU766928B2 (tr)
BR (1) BR9915214A (tr)
CA (1) CA2350062A1 (tr)
CZ (1) CZ20011655A3 (tr)
HK (1) HK1041201A1 (tr)
HU (1) HUP0104388A3 (tr)
IL (1) IL143004A0 (tr)
NO (1) NO20012300L (tr)
PL (1) PL348154A1 (tr)
TR (1) TR200101336T2 (tr)
WO (1) WO2000027434A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
AU777776B2 (en) 1999-12-23 2004-10-28 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
WO2001047509A2 (en) * 1999-12-24 2001-07-05 Smithkline Beecham P.L.C. Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
AU2001252575A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
AU2001252573A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0170416B1 (ko) * 1990-02-09 1999-02-18 로버트 에이. 아미테이지 고혈압 치료를 위한 인슐린 증감제의 용도
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE251608T1 (de) * 1996-01-10 2003-10-15 Asahi Chemical Ind Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten

Also Published As

Publication number Publication date
NO20012300D0 (no) 2001-05-10
JP2002529430A (ja) 2002-09-10
CA2350062A1 (en) 2000-05-18
TR200101336T2 (tr) 2001-11-21
WO2000027434A1 (en) 2000-05-18
EP1128845A1 (en) 2001-09-05
KR20010075698A (ko) 2001-08-09
AU766928B2 (en) 2003-10-23
NO20012300L (no) 2001-07-03
PL348154A1 (en) 2002-05-06
BR9915214A (pt) 2001-12-18
HK1041201A1 (zh) 2002-07-05
CN1332638A (zh) 2002-01-23
HUP0104388A3 (en) 2002-12-28
IL143004A0 (en) 2002-04-21
AU1063400A (en) 2000-05-29
HUP0104388A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
IL173650A0 (en) A pharmaceutical composition for treating diabetes mellitus comprising an insulin sensitizer and a biguanide antihyperglycaemic agent
HUP0200556A3 (en) Medicament for treating diabetes
HUP0400932A3 (en) Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
HUP0103714A3 (en) Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity, medicaments containing them and their use
EP1010432A4 (en) REMEDIES FOR DIABETES
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
ZA200203368B (en) Pharmaceutical composition comprising a combination of metformin and glibenclamide.
HUP0300218A3 (en) Process for treatment of diabetes, employing combination of metformin and glyburide
IL136425A0 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
IL123013A0 (en) Five-membered heterocycles having biphenylsulfonyl substitution process for their preparation their use as a medicament or diagnostic and medicaments comprising them
IL125820A0 (en) Therapeutic agent for diabetes and a pharmaceutical composition containing the same
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
CZ20011655A3 (cs) Léčivo pro léčení diabetes mellitus a stavů s ním spojených a farmaceutický prostředek obsahující beta -agonistu a daląí antidiabetické činidlo
GB2363714B (en) Herbal composition and medicament against diabetes mellitus type II manufactured thereof
HK1028200A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL134045A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
GB2355189B (en) Herbal preparation for the treatment of diabetes mellitus
IL125642A0 (en) Sulfonamide-substituted compounds processes for their preparation their use as a medicament or diagnostic and medicaments comprising them
HRP970294B1 (en) Substituted 1-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
HUP0103569A3 (en) New medicament and process for its preparation
HUP0301137A3 (en) Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same
IL143088A0 (en) A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method
AU5386098A (en) Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
HUP0102116A3 (en) Paroxetine ascorbate, process for its preparation and its pharmaceutical use
SI1054665T1 (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia